{"id":"W3022639174","doi":"10.1016/j.beha.2020.101170","title":"Establishing specific response criteria for MDS/MPN - Getting closer to reality?","year":2020,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Sierra Oncology; Astex Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; TG Therapeutics; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb","keywords":"Medicine; Multiple myeloma; Disease; Oncology; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.07743146,0.001119961,0.008539557,0.001745248,0.0007689508,0.0007755912,0.002654509,0.002902004,0.0005293494],"category_scores_gemma":[0.5242375,0.0009652768,0.001824101,0.003422155,0.001394101,0.000951799,0.003393782,0.01344457,0.006034734],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001858841,"about_ca_system_score_gemma":0.01299372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002290965,"about_ca_topic_score_gemma":0.00002667234,"domain_scores_codex":[0.9511839,0.03274611,0.005555964,0.003912953,0.003020978,0.003580084],"domain_scores_gemma":[0.7775737,0.2101885,0.001308905,0.003576116,0.004128988,0.003223796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01548223,0.001192708,0.000007525776,0.01709938,0.0007283076,0.01501303,0.0001957865,6.380538e-8,0.000009972231,0.001639449,0.3026146,0.6460169],"study_design_scores_gemma":[0.002127295,0.005724153,0.000003795386,0.01130126,0.00118961,0.007814805,0.0007191612,0.00004502649,0.000004328699,0.0002192816,0.9701087,0.0007425469],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001080635,0.8793564,0.0008945916,0.1010725,0.001151476,0.01245405,0.0003084555,0.0002415792,0.004412923],"genre_scores_gemma":[0.00001591723,0.9537293,0.03319931,0.002334452,0.004632436,0.002342463,0.000406044,0.0005102556,0.002829769],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6674941,"threshold_uncertainty_score":0.9992798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5253634270731835,"score_gpt":0.6398598484458549,"score_spread":0.1144964213726714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}